| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 6. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | hydromorphone hydrochloride (Palladone®) |
| Formulation | 2 mg/ml, 10 mg/ml, 20 mg/ml and 50 mg/ml solution for injection/infusion |
| Reference number | 1519 |
| Indication | Relief of severe pain in cancer. Hydromorphone hydrochloride is indicated in adults and adolescents aged > 12 years |
| Company | Napp Pharmaceuticals Ltd |
| BNF chapter | Central nervous system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 14/06/2017 |